Neuroscientist Matthew Sacchet is revealing how mastering meditation can not only enable transcendental states of bliss, but ...

Discover three strategies for MedTech companies to design streamlined, effective trials and how quality data powers smarter ...

Anavex (AVXL) awaits a key EU ruling on its Alzheimer’s drug. Learn about trial challenges, approval risks, and why a Sell ...

The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.

ZDNET's key takeaways Identity management is broken when it comes to AI agents. AI agents expand the threat surface of ...

The company listed all of the systems that went haywire, but never really identified what happened differently that day to ...

A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...

Columbus Business First President & Publisher Nick Fortine speaks with experts from Trace3 and Cisco about how organizations ...

The FDA’s clearance marks a significant regulatory milestone for Jupiter, enabling the Company to begin enrollment in its exploratory Phase 2a trial designed to evaluate the safety and tolerability of ...

Recognizing this need, major online messaging services use a technique called end-to-end encryption, to secure and protect users' conversations.

Milestone advances two-part study evaluating novel, locally administered gene therapy designed to increase anti-inflammatory ...

A recent study has demonstrated that the TriClip™ transcatheter tricuspid repair system (Abbott) substantially lowered the ...